FAST Study - Follow up and Active Surveillance of TIV

FAST Study - Follow up and Active Surveillance of TIV


The FAST Study is a telephone survey of parents of children who have recently received the seasonal Trivalent Influenza Vaccine (TIV). 

 

At the commencement of the seasonal 'flu vaccination programme, the Vaccine Trials Group contact a random sample of parents who attend the Rheola Street Central Immunisation Clinic to ask whether or not their children experience any side effects.

 

The aim of the study is the early identification of any problems with the current 'flu vaccines as well as providing parents and professionals with up to date information.

 

In 2014 FAST became part of AusVaxSafety, an enhanced surveillance system to monitor adverse events following immunisation with influenza vaccine in children under 5 years of age.  Using FAST data and also data from surveillance in New South Wales and Victoria, AusVaxSafety reports to the Therapeutic Goods Administration and publishes its results on their website.
 
AusVaxSaftey surveillance data from 2014 shows that seasonal influenza vaccine is safe in children under 5 years of age with reported reactions generally mild and resolving within 1 to 2 days. No serious vaccine reactions were reported.

 

Read further background information on the FAST Study.

 

Read the results for the 2014 FAST Study.

 

Read the results for the 2013 FAST Study.

 

Read the results for the 2012 FAST Study.

 

Read the results of the 2011 FAST Study.

 

     KID43 Busy Boy             KID35 Garden Girl             BAB56 Small Boy Resized